1. Home
  2. REVB vs UPC Comparison

REVB vs UPC Comparison

Compare REVB & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • UPC
  • Stock Information
  • Founded
  • REVB 2020
  • UPC 1998
  • Country
  • REVB United States
  • UPC China
  • Employees
  • REVB N/A
  • UPC N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • REVB Health Care
  • UPC Health Care
  • Exchange
  • REVB Nasdaq
  • UPC Nasdaq
  • Market Cap
  • REVB 2.3M
  • UPC 2.1M
  • IPO Year
  • REVB N/A
  • UPC 2021
  • Fundamental
  • Price
  • REVB $0.85
  • UPC $3.53
  • Analyst Decision
  • REVB
  • UPC
  • Analyst Count
  • REVB 0
  • UPC 0
  • Target Price
  • REVB N/A
  • UPC N/A
  • AVG Volume (30 Days)
  • REVB 118.3K
  • UPC 17.9K
  • Earning Date
  • REVB 11-06-2025
  • UPC 01-01-0001
  • Dividend Yield
  • REVB N/A
  • UPC N/A
  • EPS Growth
  • REVB N/A
  • UPC N/A
  • EPS
  • REVB N/A
  • UPC N/A
  • Revenue
  • REVB N/A
  • UPC $19,293,003.00
  • Revenue This Year
  • REVB N/A
  • UPC N/A
  • Revenue Next Year
  • REVB N/A
  • UPC N/A
  • P/E Ratio
  • REVB N/A
  • UPC N/A
  • Revenue Growth
  • REVB N/A
  • UPC N/A
  • 52 Week Low
  • REVB $0.84
  • UPC $2.51
  • 52 Week High
  • REVB $60.48
  • UPC $197.20
  • Technical
  • Relative Strength Index (RSI)
  • REVB 24.56
  • UPC 37.99
  • Support Level
  • REVB $0.84
  • UPC $3.35
  • Resistance Level
  • REVB $1.08
  • UPC $3.81
  • Average True Range (ATR)
  • REVB 0.08
  • UPC 0.28
  • MACD
  • REVB -0.01
  • UPC -0.06
  • Stochastic Oscillator
  • REVB 5.77
  • UPC 14.91

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: